GSCs are localized to and maintained in the glioma niche and are involved in glioblastoma vascularization and resistance to treatment (21, 39, 40).GSCs may undergo transdifferentiation into ECs, enhancing tumor resistance to currently available anti-VEGF agents (1). The gene discussed is VEGFA; the disease is neoplasm.